INS and Insulin resistance: In summary, SCs are increased in pancreatic β-cells and key insulin-regulated metabolic organs with aging, obesity, and diabetes and contribute to inflammation and associated insulin resistance, hyperglycemia, and dyslipidemia, representing an opportunity for therapeutic development for these disorders.